These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 4835598)
21. Allantoxanamide: a potent new uricase inhibitor in vivo. Johnson WJ; Chartrand A Life Sci; 1978 Nov; 23(22):2239-44. PubMed ID: 723476 [No Abstract] [Full Text] [Related]
22. [Hyperuricemia, gout and gout-induced nephropathy]. Arkhipov VE; Borisov IA; Nasonov EL; Sura VV Ter Arkh; 1980; 52(4):133-42. PubMed ID: 6996182 [No Abstract] [Full Text] [Related]
24. Control of uric acid excretion. Steele TH N Engl J Med; 1971 May; 284(21):1193-6. PubMed ID: 4929385 [No Abstract] [Full Text] [Related]
25. [Comparative study of uric acid renal elimination in the gout patients and normal patients in spontaneous or experimentally increased or decreased uricemia]. Prost A; Fontenaille C; Guiheneuc P; Héron B; Lucas J Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):33-9. PubMed ID: 4820524 [No Abstract] [Full Text] [Related]
26. Uricase inhibition in the rat by s-triazines: an animal model for hyperuricemia and hyperuricosuria. Johnson WJ; Stavric B; Chartrand A Proc Soc Exp Biol Med; 1969 May; 131(1):8-12. PubMed ID: 5770131 [No Abstract] [Full Text] [Related]
27. Diminished renal urate secretion per nephron as a basis for primary gout. Rieselbach RE; Sorensen LB; Shelp WD; Steele TH Ann Intern Med; 1970 Sep; 73(3):359-66. PubMed ID: 4917177 [No Abstract] [Full Text] [Related]
28. [Apparently primary kidney disease revealing latent error of purine metabolism in 2 adolescents]. Lagrue G; Canlorbe P; Busuttil R Ann Pediatr (Paris); 1969 Oct; 16(10):567-72. PubMed ID: 5357395 [No Abstract] [Full Text] [Related]